Clinical trial NCT01682603 - References

Spinal Cord Injuries — Effect of Botulinum Toxin A on Detrusor Overactivity and Renal Function in Chronic Spinal Cord Injured Patients

Citation(s)

•   Ahmed HU, Shergill IS, Arya M, Shah PJ
  Management of detrusor-external sphincter dyssynergia. Nat Clin Pract Urol. 2006 Jul;3(7):368-80. Review.
•   Aoki KR
  Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache. 2003 Jul-Aug;43 Suppl 1:S9-15. Review.
•   Apostolidis A, Popat R, Yiangou Y, Cockayne D, Ford AP, Davis JB, Dasgupta P, Fowler CJ, Anand P
  Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol. 2005 Sep;174(3):977-82; discussion 982-3.
•   Avelino A, Cruz C, Nagy I, Cruz F
  Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience. 2002;109(4):787-98.
•   Chan CL, Facer P, Davis JB, Smith GD, Egerton J, Bountra C, Williams NS, Anand P
  Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet. 2003 Feb 1;361(9355):385-91.
•   Chartier-Kastler E, Comperat E, Ruffion A
  [Disorders of bladder compliance and neurogenic bladder]. Prog Urol. 2007 May;17(3):442-7. French.
•   Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain G, Berson A, Kassotakis L, Hedley L, Lachnit WG, Burnstock G, McMahon SB, Ford AP
  Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature. 2000 Oct 26;407(6807):1011-5.
•   Cruz F, Avelino A, Cruz C, et al
  Sensory fibers immunoreactive to the vanilloid receptor protein: Distribution in the urinary bladder. Neurourol Urodynam 19:456, 2000.
•   Cruz F, Guimaräes M, Silva C, Reis M
  Suppression of bladder hyperreflexia by intravesical resiniferatoxin. Lancet. 1997 Aug 30;350(9078):640-1.
•   Cui M, Aoki KR
  Botulinum toxin type A(BTX-A) reduces inflammatory pain in the rat formalin model. Cephalalgia 20:414, 2000.
•   Durham PL, Cady R, Cady R
  Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache. 2004 Jan;44(1):35-42; discussion 42-3.
•   Ethans KD, Nance PW, Bard RJ, Casey AR, Schryvers OI
  Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity. J Spinal Cord Med. 2004;27(3):214-8.
•   Fowler CJ, Beck RO, Gerrard S, Betts CD, Fowler CG
  Intravesical capsaicin for treatment of detrusor hyperreflexia. J Neurol Neurosurg Psychiatry. 1994 Feb;57(2):169-73.
•   Gabella G
  The structural relations between nerve fibres and muscle cells in the urinary bladder of the rat. J Neurocytol. 1995 Mar;24(3):159-87.
•   Gerridzen RG, Thijssen AM, Dehoux E
  Risk factors for upper tract deterioration in chronic spinal cord injury patients. J Urol. 1992 Feb;147(2):416-8.
•   Giannantoni A, Di Stasi SM, Nardicchi V, Zucchi A, Macchioni L, Bini V, Goracci G, Porena M
  Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. J Urol. 2006 Jun;175(6):2341-4.
•   Giannantoni A, Di Stasi SM, Stephen RL, Bini V, Costantini E, Porena M
  Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. J Urol. 2004 Jul;172(1):240-3.
•   Giannantoni A, Scivoletto G, Di Stasi SM, Silecchia A, Finazzi-Agrò E, Micali I, Castellano V
  Clean intermittent catheterization and prevention of renal disease in spinal cord injury patients. Spinal Cord. 1998 Jan;36(1):29-32.
•   Grosse J, Kramer G, Stöhrer M
  Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol. 2005 May;47(5):653-9. Epub 2005 Jan 15.
•   Kuo HC
  Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. J Urol. 2003 Nov;170(5):1908-12.
•   Kuo HC
  Therapeutic effects of suburothelial injection of botulinum a toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions. Urology. 2006 Feb;67(2):232-6. Epub 2006 Jan 25.
•   Kuo HC
  Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Urology. 2004 May;63(5):868-72.
•   Linsenmeyer TA, Bagaria SP, Gendron B
  The impact of urodynamic parameters on the upper tracts of spinal cord injured men who void reflexly. J Spinal Cord Med. 1998 Jan;21(1):15-20.
•   MacDiarmid SA, McIntyre WJ, Anthony A, Bailey RR, Turner JG, Arnold EP
  Monitoring of renal function in patients with spinal cord injury. BJU Int. 2000 Jun;85(9):1014-8.
•   Morrison J, Wen J, Kibble A
  Activation of pelvic afferent nerves from the rat bladder during filling. Scand J Urol Nephrol Suppl. 1999;201:73-5.
•   Namasivayam S, Eardley I, Morrison JF
  Purinergic sensory neurotransmission in the urinary bladder: an in vitro study in the rat. BJU Int. 1999 Nov;84(7):854-60.
•   Nosseir M, Hinkel A, Pannek J
  Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury. Neurourol Urodyn. 2007;26(2):228-33.
•   Pannek J, Sommerfeld HJ, Bötel U, Senge T
  Combined intravesical and oral oxybutynin chloride in adult patients with spinal cord injury. Urology. 2000 Mar;55(3):358-62.
•   Patel AK, Patterson JM, Chapple CR
  Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: A critical analysis of results. Eur Urol. 2006 Oct;50(4):684-709; discussion 709-10. Epub 2006 Aug 4. Review.
•   Razdan S, Leboeuf L, Meinbach DS, Weinstein D, Gousse AE
  Current practice patterns in the urologic surveillance and management of patients with spinal cord injury. Urology. 2003 May;61(5):893-6.
•   Reitz A, Stöhrer M, Kramer G, Del Popolo G, Chartier-Kastler E, Pannek J, Burgdörfer H, Göcking K, Madersbacher H, Schumacher S, Richter R, von Tobel J, Schurch B
  European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol. 2004 Apr;45(4):510-5.
•   Samson G, Cardenas DD
  Neurogenic bladder in spinal cord injury. Phys Med Rehabil Clin N Am. 2007 May;18(2):255-74, vi. Review.
•   Schrader AJ, Lauber J, Lechner O, Heidenreich A, Hofmann R, Buer J
  Application of real-time reverse transcriptase-polymerase chain reaction in urological oncology. J Urol. 2003 May;169(5):1858-64. Review.
•   Schulte-Baukloh H, Schobert J, Stolze T, Stürzebecher B, Weiss C, Knispel HH
  Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis. Neurourol Urodyn. 2006;25(2):110-5.
•   Schulte-Baukloh H, Weiss C, Stolze T, Herholz J, Stürzebecher B, Miller K, Knispel HH
  Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction. Eur Urol. 2005 Dec;48(6):984-90; discussion 990. Epub 2005 Jul 18.
•   Schurch B, de Sèze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, Plante P, Perrouin-Verbe B, Kumar C, Fraczek S, Brin MF; Botox Detrusor Hyperreflexia Study Team
  Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol. 2005 Jul;174(1):196-200.
•   Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB
  Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol. 1996 Mar;155(3):1023-9.
•   Schurch B, Stöhrer M, Kramer G, Schmid DM, Gaul G, Hauri D
  Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol. 2000 Sep;164(3 Pt 1):692-7.
•   Sekar P, Wallace DD, Waites KB, DeVivo MJ, Lloyd LK, Stover SL, Dubovsky EV
  Comparison of long-term renal function after spinal cord injury using different urinary management methods. Arch Phys Med Rehabil. 1997 Sep;78(9):992-7.
•   Shu SY, Ju G, Fan LZ
  The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett. 1988 Feb 29;85(2):169-71.
•   Silva C, Rio ME, Cruz F
  Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia. Eur Urol. 2000 Oct;38(4):444-52.
•   Steers WD
  Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol. 2002;4 Suppl 4:S7-S18.
•   Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA
  Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn. 1995;14(2):131-9.
•   Weld KJ, Dmochowski RR
  Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury. Urology. 2000 Apr;55(4):490-4.
•   Weld KJ, Graney MJ, Dmochowski RR
  Clinical significance of detrusor sphincter dyssynergia type in patients with post-traumatic spinal cord injury. Urology. 2000 Oct 1;56(4):565-8.
•   Weld KJ, Graney MJ, Dmochowski RR
  Differences in bladder compliance with time and associations of bladder management with compliance in spinal cord injured patients. J Urol. 2000 Apr;163(4):1228-33.
•   Wiseman OJ, Fowler CJ, Landon DN
  The role of the human bladder lamina propria myofibroblast. BJU Int. 2003 Jan;91(1):89-93.
•   Yiangou Y, Facer P, Ford A, Brady C, Wiseman O, Fowler CJ, Anand P
  Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder. BJU Int. 2001 Jun;87(9):774-9.
•   Yono M, Takahashi W, Pouresmail M, Johnson DR, Foster HE Jr, Weiss RM, Latifpour J
  Quantification of endothelins, their receptors, and endothelin-converting enzyme mRNAs in rat genitourinary tract using real-time RT-PCR. J Pharmacol Toxicol Methods. 2002 Sep-Oct;48(2):87-95.

Effect of Botulinum Toxin A on Detrusor Overactivity and Renal Function in Chronic Spinal Cord Injured Patients - Clinical Effects and Investigating Mechanism of Action

Details for clinical trial NCT01682603